Abstract

Hospice Symptom Relief Kit: An Update

Author(s): Petrin Ronald L

Issue: Jul/Aug 2006 - Sterile Preparations

Page(s): 288-290

Download in electronic PDF format for $75

Abstract

A hospice patient’s condition can change quickly and dramatically. Because of the unpredictability of sudden changes in a hospice patient’s pain and other symptoms, planning ahead is essential when it comes to preventing needless suffering. To be prepared for such changes, the author developed what was originally called the Hospice Emergency Kit, which has now been more appropriately renamed the Symptom Relief Kit. The rationale for the kit is to have patient-specific medications ready and readily available before the patient actually needs them. Having these kits available allows hospice care providers to treat their patients with the dignity and care they deserve.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2006 Pg. 288-290	Hospice Symptom Relief Kit: An Update Author(s): Petrin Ronald L
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
Mar/Apr 1998 Pg. 116-117	The Symptom Relief Kit for Hospice Patients Author(s): Petrin Ronald L
Mar/Apr 2006 Pg. 89-93	Hospice from a Compounding Pharmacist's Perspective Author(s): Jones Marty
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Jan/Feb 2008 Pg. 28-37	Hospice and Compounding Pharmacy: Once Inseperable Author(s): Williams LaVonn A
May/Jun 2003 Pg. 183	ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 147-153	Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Author(s): Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
Jul/Aug 2000 Pg. 246-249	Hospice and the Role of the Compounding Pharmacist Author(s): Carling Maureen A
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 297	Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 452-455	Palliative Care and Compounding for Household Pets Author(s): Gaskins Jessica L
Jan/Feb 2007 Pg. 10-15	Principles of Pediatric Palliative Care and Pain Control Author(s): Peralta Alexander Jr
Mar/Apr 2006 Pg. 100-102	The Story of Hospice Author(s): Kuntz Rachael
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Sep/Oct 2012 Pg. 364-368	Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report Author(s): McNulty Jack P, Hahn Kristian